New hope for men battling Tough-to-Treat prostate cancer
NCT ID NCT06970119
Summary
This study is testing a new injection called INR102 for men with advanced prostate cancer that has spread and stopped responding to standard hormone and chemotherapy treatments. The main goals are to see if the treatment is safe, how the body processes it, and if it can help reduce prostate cancer activity. Researchers will enroll about 55 men whose cancer tests positive for a specific marker called PSMA.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Jiangnan University
NOT_YET_RECRUITINGWuxi, Jiangsu, 214000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tianjin Cancer Hospital Airport Hospital
RECRUITINGTianjin, Tianjin Municipality, 300000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.